Top Markets
#1 Akedo Akedo +73.50%
#2 MEET48 MEET48 +26.11%
#3 Bitway Bitway +21.76%
#4 VeThor VeThor +21.08%
#5 Power Protocol Power Protocol +17.38%
#6 Tutorial Tutorial +16.23%
#7 Astar Astar +14.86%
#8 龙虾 (Lobster) 龙虾 (Lobster) +12.72%
#9 Falcon Finance Falcon Finance +12.11%
#10 Arbitrum Arbitrum +12.09%
Coin of the day
Akedo Akedo
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Rang în acțiuni #37014
Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating... Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating therapies for the acute phase of thrombotic conditions. The company's lead compound, glenzocimab, is a humanized monoclonal antibody fragment specifically designed to target a particular platelet glycoprotein. Currently, Acticor Biotech is advancing two clinical programs, both in Phase II/III, for the registration of treatments for ischemic stroke. Additionally, it is conducting two other Phase II trials concerning significant cardiovascular emergencies, with anticipated clinical data expected from both its ischemic stroke research and studies related to COVID-19 respiratory distress syndrome. Established in 2013, the company operates from its headquarters in Paris, France.
Preț acțiune
$0.25974701
Ultima sincronizare: 2025-01-06
Capitalizare de piață
$2.04M
Schimbare (1 zi)
0.74%
Schimbare (1 an)
0.00%
Țară
FR
Tranzacționează Acticor Biotech SAS (ALACT)

Categorie

Healthcare
Raport P/B pentru Acticor Biotech SAS (ALACT)
Raport P/B la data de September 2026 TTM: -0.57
Conform celor mai recente rapoarte financiare și prețului acțiunilor Acticor Biotech SAS, raportul P/B actual (TTM) este -0.57. La sfârșitul anului 2022, compania avea un P/B de -33.19.
Istoricul raportului P/B pentru Acticor Biotech SAS din 2010 până în 2026
Raport P/B la sfârșitul fiecărui an
An Raport P/B Schimbă
2026 (TTM) -0.57 -91.38%
2023 -6.59 -80.15%
2022 -33.19 -1,126.36%
2021 3.23 -87.62%
2020 26.12 538.96%
2019 4.09 17.85%
2018 3.47 -160.01%
2017 -5.78 -511.84%
2016 1.40 2.83%
2015 1.37 7.92%
2014 1.26 5.23%
2013 1.20 -8.34%
2012 1.31 -12.44%
2011 1.50 -91.22%
2010 17.05 0.00%
Raport P/B pentru companii similare sau competitoare
Companie Raport P/B Diferență raport P/B Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.5144 -1,247.10%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.3983 -1,402.75%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 3.9974 -803.89%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 8.5918 -1,612.91%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH